You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell Non-Hodgkin Lymphoma (B-cell NHL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • UCART20x22
  • CLLS52
  • Austin, Texas
    Sarah Cannon - St. David South Austin Medical Center
Dec 8, 2022

Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Perth, Western Australia, Australia
    Linear Clinical Research Ltd
Apr 20, 2023

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

    Suspended
    • NHL
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 31, 2023

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • BTK inhibitor
      • PD-1 inhibitor
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      May 20, 2023

      Non-Hodgkin's Lymphoma Trial (MBS303)

      Not yet recruiting
      • Non-Hodgkin's Lymphoma
      • (no location specified)
      Apr 6, 2023

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

      Not yet recruiting
      • B-cell Non-Hodgkins Lymphoma (B-NHL)
      • (no location specified)
      Jan 5, 2023

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

      Not yet recruiting
      • Non Hodgkin's Lymphoma
      • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
      • +2 more
      • Beijing, China
      • +2 more
      Aug 23, 2023

      B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B-cell Non Hodgkin Lymphoma
      • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
      • Aurora, Colorado
        Children's Hospital Colorado
      Nov 9, 2022

      Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

      Recruiting
      • Non-hodgkin Lymphoma,B Cell
      • Autologous CD19-STAR-T cell
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2022

      B-cell NHL, CLL Trial (CARCIK-CD19)

      Not yet recruiting
      • B-cell NHL
      • CLL
      • CARCIK-CD19
      • (no location specified)
      May 19, 2023

      B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma (B-NHL)
      • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
      • PIT565
      • (no location specified)
      Jun 13, 2022

      Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma, Relapsed
      • +8 more
      • PBCAR20A
      • +2 more
      • Duarte, California
      • +4 more
      Jan 4, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

      Active, not recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Lymphoma, Non-Hodgkin
      • Copenhagen, Denmark
      • +9 more
      Jan 27, 2023

      CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

      Recruiting
      • CAR
      • +2 more
      • ThisCART19A with Dose Level 1
      • ThisCART19A with Dose Level 2
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jan 18, 2023